Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019

Cell Mol Immunol. 2020 Oct;17(10):1092-1094. doi: 10.1038/s41423-020-00522-6. Epub 2020 Sep 11.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Betacoronavirus / immunology
  • Betacoronavirus / pathogenicity*
  • Biomarkers / blood
  • COVID-19
  • Coronavirus Infections / complications*
  • Coronavirus Infections / immunology
  • Coronavirus Infections / mortality
  • Coronavirus Infections / virology
  • Critical Illness
  • Cytokine Release Syndrome / complications*
  • Cytokine Release Syndrome / immunology
  • Cytokine Release Syndrome / mortality
  • Cytokine Release Syndrome / virology
  • Humans
  • Interferon-gamma / blood
  • Interferon-gamma / immunology
  • Interleukin-10 / blood
  • Interleukin-10 / immunology
  • Interleukin-2 / blood
  • Interleukin-2 / immunology
  • Interleukin-4 / blood
  • Interleukin-4 / immunology
  • Interleukin-6 / blood
  • Interleukin-6 / immunology*
  • Lymphopenia / complications*
  • Lymphopenia / immunology
  • Lymphopenia / mortality
  • Lymphopenia / virology
  • Pandemics
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / immunology
  • Pneumonia, Viral / mortality
  • Pneumonia, Viral / virology
  • Procalcitonin / blood
  • Procalcitonin / immunology
  • SARS-CoV-2
  • Sepsis / complications*
  • Sepsis / immunology
  • Sepsis / mortality
  • Sepsis / virology
  • Survival Analysis
  • Tumor Necrosis Factor-alpha / blood
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • Biomarkers
  • IL10 protein, human
  • IL4 protein, human
  • IL6 protein, human
  • Interleukin-2
  • Interleukin-6
  • Procalcitonin
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Interleukin-4
  • Interferon-gamma